July 25, 2017 12:58 PM ET

Diversified Consumer Services

Company Overview of University of Miami

Company Overview

The University of Miami is an educational and research institution that includes the Rosenstiel School of Marine and Atmospheric Science, the Medical Campus, the John J. Koubek Center, and the James L. Knight Center. The university offers certificates, bachelors, masters, doctoral, first professional, post-masters, and post-bachelors degrees. Its 13 colleges and schools offer 110 undergraduate, 100 masters, 68 doctoral, and two professional areas of study including architecture, biology, chemistry, communications, engineering, medicine, physics, psychology, sociology, and international relations. The University of Miami was founded in 1925 and is based in Coral Gables, Florida. It has endowm...

Memorial Drive

Coral Gables, FL 33146-4616

United States

Founded in 1925

Phone:

305-284-4323

Fax:

305-284-2507

Key Executives for University of Miami

Dean of College of Arts and Sciences
Chief Financial Officer and Senior Vice President of Business & Finance
Associate Director of the Center for Advanced Supply Chain Management
Age: 77
Senior Vice President for Medical Affairs and Dean of Leonard M. Miller School of Medicine
Age: 62
Executive Vice President and Provost
Compensation as of Fiscal Year 2017.

University of Miami Key Developments

University of Miami Appoints Andy Gomez as Interim Director of ICCAS Effective August 15, 2017

The University of Miami announced that Andy Gomez, a respected community leader and former assistant provost and senior fellow at UM's Institute for Cuban and Cuban-American Studies (ICCAS), will serve as interim director of ICCAS effective August 15, 2017. Gomez, an expert on human values and attitudes in post-Castro Cuba, was presented the University's President's Medal when he retired in 2012. He continues to be a much sought after media expert on Cuba and Cuban-American relations. As a committed leader in the field of Cuban studies, the University of Miami will conduct an extensive search to identify and hire an accomplished scholar in Cuban and Cuban-American studies to continue the research and partnerships housed at Casa Bacardi. Gomez will also serve as an advisor to the University in this area.

University of Miami Appoints Jacqueline A. Travisano as COO and Executive VP, Effective June 1, 2017

The University of Miami announced its new COO and executive VP for business and finance, hiring Jacqueline A. Travisano from Nova Southeastern University in Davie. Travisano has been executive VP and COO at NSU since 2011. Before that, she was VP for business affairs and CFO at St. Johns University. She will start on June 1, 2017, until then, David Ertelwill will continue to serve as interim senior VP and CFO. She will be responsible for all financial functions plus information technology, campus planning, and facilities design and construction.

Heat Biologics and University of Miami Announce Zika Vaccine Collaboration

Heat Biologics, Inc. announced that it has entered into an agreement with the University of Miami for the license and development of a portfolio of patents leveraging its gp96 platform to target the Zika virus and other infectious diseases. Heat has formed a wholly-owned subsidiary, Zolovax, Inc., to focus on the development of gp96-based vaccines targeting Zika, HIV, West Nile, dengue and yellow fever. Clinical and preclinical studies suggest that Heat’s gp96 platform may have a role as a broad-based infectious disease vaccine. Heat has treated more than 200 cancer patients to date with its gp96-based therapeutic vaccines (HS-110 and HS-410), which have induced strong antigen-specific immune response, with an excellent safety profile. In the case of Zika, the placenta is believed to play a key role in virus transmission from mother to fetus. Researchers have observed profound pathological changes in Zika-infected placentas, suggesting that the placenta’s naturally protective barrier function is impaired during Zika infection.  Heat believes that the robust mucosal immune response generated by gp96 in ongoing studies supports the development of a gp96 vaccine that could also stimulate a Zika-specific immune response in the placenta, thus protecting the fetus from virus transmission.

Similar Private Companies By Industry

Company Name Region
1-800-Dryclean, LLC United States
1-800-PHONESEX United States
125 Max Drycleaning Center LLC United States
180 Skills LLC United States
19Pencils, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact University of Miami, please visit www.miami.edu. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.